Follow
Chaitanya mulakayala
Chaitanya mulakayala
Department of Biosciences, Sri Satya Sai Institute of Higher Learning, Department of Biochemistry
Verified email at sssihl.edu.in
Title
Cited by
Cited by
Year
Synthesis of novel 2-mercapto benzothiazole and 1, 2, 3-triazole based bis-heterocycles: their anti-inflammatory and anti-nociceptive activities
S Shafi, MM Alam, N Mulakayala, C Mulakayala, G Vanaja, AM Kalle, ...
European journal of medicinal chemistry 49, 324-333, 2012
3242012
Catalysis by molecular iodine: a rapid synthesis of 1, 8-dioxo-octahydroxanthenes and their evaluation as potential anticancer agents
N Mulakayala, P Murthy, D Rambabu, M Aeluri, R Adepu, GR Krishna, ...
Bioorganic & Medicinal Chemistry Letters 22 (6), 2186-2191, 2012
1322012
Sulfur rich 2-mercaptobenzothiazole and 1, 2, 3-triazole conjugates as novel antitubercular agents
F Mir, S Shafi, MS Zaman, NP Kalia, VS Rajput, C Mulakayala, ...
European Journal of Medicinal Chemistry 76, 274-283, 2014
1142014
Synthesis of some novel chalcones, flavanones and flavones and evaluation of their anti-inflammatory activity
S Bano, K Javed, S Ahmad, IG Rathish, S Singh, M Chaitanya, ...
European Journal of Medicinal Chemistry 65, 51-59, 2013
1092013
Ultrasound mediated catalyst free synthesis of 6< i> H</i>-1-benzopyrano [4, 3-< i> b</i>] quinolin-6-ones leading to novel quinoline derivtives: Their evaluation as potential …
N Mulakayala, D Rambabu, MR Raja, M Chaitanya, CS Kumar, AM Kalle, ...
Bioorganic & Medicinal Chemistry, 2011
732011
InCl3-catalysed synthesis of 2-aryl quinazolin-4 (3H)-ones and 5-aryl pyrazolo [4, 3-d] pyrimidin-7 (6H)-ones and their evaluation as potential anticancer agents
N Mulakayala, B Kandagatla, RK Rapolu, P Rao, C Mulakayala, ...
Bioorganic & medicinal chemistry letters 22 (15), 5063-5066, 2012
612012
Exploring the molecular basis for selective binding of Mycobacterium tuberculosis Asp kinase toward its natural substrates and feedback inhibitors: A docking and molecular …
M Chaitanya, B Babajan, CM Anuradha, M Naveen, C Rajasekhar, ...
Journal of molecular modeling 16 (8), 1357-1367, 2010
442010
2, 3-Diaryl-3H-imidazo [4, 5-b] pyridine derivatives as potential anticancer and anti-inflammatory agents
EM Kirwen, T Batra, C Karthikeyan, GS Deora, V Rathore, C Mulakayala, ...
Acta Pharmaceutica Sinica B 7 (1), 73-79, 2017
272017
Comprehensive structural and functional characterization of Mycobacterium tuberculosis UDP-NAG enolpyruvyl transferase (Mtb-MurA) and prediction of its …
B Babajan, M Chaitanya, C Rajsekhar, D Gowsia, P Madhusudhana, ...
Interdisciplinary Sciences: Computational Life Sciences 3, 204-216, 2011
262011
Probing ligand binding modes of Mycobacterium tuberculosis MurC ligase by molecular modeling, dynamics simulation and docking
CM Anuradha, C Mulakayala, B Babajan, M Naveen, C Rajasekhar, ...
Journal of molecular modeling 16, 77-85, 2010
262010
Design, synthesis and anticancer activity of N-(1-(4-(dibenzo [b, f][1, 4] thiazepin-11-yl) piperazin-1-yl)-1-oxo-3-phenylpropan-2-yl derivatives
MR Gudisela, N Srinivasu, C Mulakayala, P Bommu, MVB Rao, ...
Bioorganic & Medicinal Chemistry Letters 27 (17), 4140-4145, 2017
252017
Synthesis of novel spiro [pyrazolo [4, 3-d] pyrimidinones and spiro [benzo [4, 5] thieno [2, 3-d] pyrimidine-2, 3′-indoline]-2′, 4 (3H)-diones and their evaluation for …
B Kuthati, G Thalari, V Bommarapu, C Mulakayala, SK Chitta, ...
Bioorganic & Medicinal Chemistry Letters 27 (6), 1446-1450, 2017
252017
Synthesis and evaluation of resveratrol derivatives as new chemical entities for cancer
C Mulakayala, B Babajan, P Madhusudana, CM Anuradha, RM Rao, ...
Journal of Molecular Graphics and Modelling 41, 43-54, 2013
252013
Synthesis and pharmacological evaluation of N-substituted 2-(2-oxo-2H-chromen-4-yloxy) propanamide as cyclooxygenase inhibitors
D Rambabu, N Mulakayala, KR Kumar, GP Kumar, C Mulakayala, ...
Bioorganic & medicinal chemistry letters 22 (21), 6745-6749, 2012
212012
Molecular Modeling and Docking Studies of O-Succinylbenzoate Synthase of M. tuberculosis—a Potential Target for Antituberculosis Drug Design
M Pulaganti, B Banaganapalli, C Mulakayala, SK Chitta, A CM
Applied biochemistry and biotechnology 172, 1407-1432, 2014
202014
Synthesis of novel 2-mercapto benzothiazole and 1, 2, 3-triazole based bisheterocycles: Their anti-inflammatory and anti-nociceptive activities
S Syed, MM Alam, N Mulakayala, C Mulakayala, G Vanaja, AM Kalle, ...
Eur. J. Med. Chem 49, 324-333, 2012
192012
Preparation, characterization and evaluation of finasteride ethosomes
S Sujatha, G Sowmya, M Chaitanya, VSK Reddy, M Monica, KK Kumar, ...
Int J Drug Delivery 8, 01-11, 2016
172016
Molecular docking and dynamics simulations of A.niger RNase from Aspergillus niger ATCC26550: for potential prevention of human cancer
GR Kumar, R Chikati, SL Pandrangi, M Kandapal, K Sonkar, N Gupta, ...
Journal of molecular modeling 19, 613-621, 2013
172013
An improved RP-HPLC method for the quantitative determination of Capecitabine in bulk and pharmaceutical tablet dosage form
P Ravisankar, GD Rao, MN Kumar, MK Chaitanya
Pharmacia. Lettre 5, 249-260, 2013
152013
Experimental and computational studies on newly synthesized resveratrol derivative: a new method for cancer chemoprevention and therapeutics?
B Banaganapalli, C Mulakayala, M Pulaganti, N Mulakayala, ...
OMICS: A Journal of Integrative Biology 17 (11), 568-583, 2013
142013
The system can't perform the operation now. Try again later.
Articles 1–20